CONNECT WITH US
Tech

Tech

Temple by Deepinder Goyal Goes on Pre-Orders at Rs 85000

TelecomTalk - Tech logo

Published on

Add as a preferred source on Google
Temple by Deepinder Goyal Goes on Pre-Orders at Rs 85000

Zomato’s Ex-CEO Deepinder Goyal took over the internet with the announcement of pre-orders for its new health wearable, Temple, in India after a long wait. Deepinder Goyal, who ran Ethernal, Zomato’s parent company, resigned to launch Temple in India. Recently, Deepinder Goyal also took over the internet when he appeared on Raj Shamani’s podcast wearing the new Temple wearable.

Although it was in the experimental phase, Temple has now announced its public release, with pre-orders starting today and delivery promised within the next 3 months. Temple is available in five colours, priced at Rs 85,000 in India. Here is what you get with Temple.

For readers who aren’t aware, Temple is a new healthcare wearable created by Deepinder Goyal, the founder of the online food-ordering platform Zomato.

Deepinder Goyal reportedly left Zomato to start Temple, entering next-generation healthcare tech.

Temple is a 24×7 healthcare companion that attaches with a medical-grade grip on the side of the head, just behind the eyes and between the forehead and ears.

Temple has not shared internal specifications, but it has shared key features, including lifetime subscription access to health features that help monitor and track data.

Temple also promises “Temple Care”, where the device can be replaced for a nominal fee for life in case of damage. It also offers personal onboarding, where an associate provides a one-on-one introduction and guidance to use Temple.

Temple alsoTemple also promises a lifetime supply of grips, using medical-grade adhesives to stick its wearable devices. You also get a charging pod, and Temple can run up to 25 days on a single charge.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.